Skip to main content
. 2017 Dec 1;29(4):979–984. doi: 10.1093/annonc/mdx771

Table 3.

Adverse events (N)

Adverse events Grade 1 Grade 2 Grade 3 Grade 4
Anemia 20 1 0 0
Leukocytosis 1 1 1 0
Platelet count decreased 1 0 1 0
Hyponatremia 3 0 0 0
Hypernatremia 2 0 0 0
Hyperkalemia 4 1 0 0
AST/ALT increased 8 0 2 0
Cr increased 6 0 2 0
Hot flashes 9 0 0 0
Constipation 3 0 0 0
Malaise 1 0 0 0
Penile pain 1 0 0 0
Device related infection 0 0 1 0
Upper respiratory infection 0 1 0 0
Arthralgia 1 0 0 0
Urinary frequency 2 0 0 0
Depression 1 0 0 0
Pruritus 1 0 0 0
Gynecomastia 1 0 0 0
Laryngopharyngeal dysesthesia 1 0 0 0
Irregular menstruation 1 0 0 0
Dizziness 2 0 0 0
Dysgeusia 1 0 0 0
Erythema multiforme 1 0 0 0

AST/ALT, alanine transaminase/aspartate aminotransferase ratio; Cr, creatinine.